There are also trimester-specific changes with which women will have to cope, including a greater risk of hypoglycemia in the first trimester (particularly for women with T1D), insulin resistance in the second and third trimesters leading to increased insulin needs, and induction planning at the end of the third trimester [1, 2]. The gene discussed is INS; the disease is Hypoglycemia.